Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
The aim of our study was to compare apolipoprotein B (apoB), non-high density lipoprotein cholesterol (nonHDL-C), low density lipoprotein cholesterol (LDL-C), and other lipid markers as predictors of coronary heart disease (CHD) in Chinese. Overall, 122 individuals developed CHD during a median 13.6 years of follow-up in 3,568 adult participants from a community-based cohort. The multivariate relative risk of CHD in the highest quintile compared with the lowest quintile was 2.74 [95% confidence interval (CI), 1.45-5.19] for apoB, 1.98 (95% CI, 1.00-3.92) for nonHDL-C, and 1.86 (95% CI, 1.00-3.49) for LDL-C (all tests for trend, P < 0.05). ApoB also had the highest receiver operator characteristic curve area (0.63; 95% CI, 0.58-0.68) in predicting CHD. When apoB and nonHDL-C were mutually adjusted, only apoB was predictive; the relative risk was 2.80 (95% CI, 1.31-5.96; P = 0.001) compared with 1.09 (95% CI, 0.49-2.40; P = 0.75) for nonHDL-C. Compared with the lowest risk, participants with the highest apoB and total cholesterol/HDL-C had a 3-fold increased risk of developing CHD (relative risk = 3.21; 95% CI, 1.45-7.14). These data provide strong evidence that apoB concentration was a better predictor of CHD than other lipid markers in Chinese.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, the beneficial effect of statins is not apparent in persons who require dialysis.333,357,411–413”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [333]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Therapy with statins reduces the relative risk of major vascular events in persons with DM by 17% for every 39 mg/dL decrease in LDL-C.333”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [333]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Hosmer, D. W., & Lemeshow, S. (2000) · doi:10.1002/0471722146 · Cited by 20,302
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Hanley, J. A., & McNeil, B. J. (1983) · Radiology · doi:10.1148/radiology.148.3.6878708 · Cited by 7,016
Proportional hazards tests and diagnostics based on weighted residuals
GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika · doi:10.1093/biomet/81.3.515 · Cited by 5,885
Greiner, M., Pfeiffer, D., & Smith, R. D. (2000) · Preventive Veterinary Medicine · doi:10.1016/s0167-5877(00)00115-x · Cited by 1,923
Walldius, G., Jungner, I., Holme, I., Aastveit, A. H., Kolar, W., & Steiner, E. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07098-2 · Cited by 1,229
Ridker, P. M., Rifai, N., Cook, N. R., Bradwin, G., & Buring, J. E. (2005) · JAMA · doi:10.1001/jama.294.3.326 · Cited by 744
Non–High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality
Cui, Y., Blumenthal, R. S., Flaws, J. A., Whiteman, M. K., Langenberg, P., Bachorik, P. S., & Bush, T. L. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.11.1413 · Cited by 658
WALLDIUS, G., & JUNGNER, I. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01643.x · Cited by 583
Pischon, T., Girman, C. J., Sacks, F. M., Rifai, N., Stampfer, M. J., & Rimm, E. B. (2005) · Circulation · doi:10.1161/circulationaha.104.532499 · Cited by 514
Lamarche, B., Moorjani, S., Lupien, P. J., Cantin, B., Bernard, P.-M., Dagenais, G. R., & Despre´s, J.-P. (1996) · Circulation · doi:10.1161/01.cir.94.3.273 · Cited by 476
Lehto, S., Rönnemaa, T., Haffher, S. M., Pyörälä, K., Kallio, V., & Laakso, M. (1997) · Diabetes · doi:10.2337/diab.46.8.1354 · Cited by 375
Non-HDL Cholesterol as a Predictor of Cardiovascular Disease in Type 2 Diabetes
Lu, W., Resnick, H. E., Jablonski, K. A., Jones, K. L., Jain, A. K., Howard, W. J., Robbins, D. C., & Howard, B. V. (2003) · Diabetes Care · doi:10.2337/diacare.26.1.16 · Cited by 370
Jiang, R., Schulze, M. B., Li, T., Rifai, N., Stampfer, M. J., Rimm, E. B., & Hu, F. B. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.1991 · Cited by 238
Self-citationApolipoprotein Concentrations During Treatment and Recurrent Coronary Artery Disease Events
van Lennep, J. E. R., Westerveld, H. T., van Lennep, H. W. O. R., Zwinderman, A. H., Erkelens, D. W., & van der Wall, E. E. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.11.2408 · Cited by 153
Chien, K., HSU, H., Sung, F. C., Su, T., Chen, M., & Lee, Y. L. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.01.018 · Cited by 135
Self-citationLee, Y., Lin, R. S., Sung, F. C., Yang, C.-Y., Chien, K., Chen, W., Su, T., Hsu, H.-C., & Huang, Y.-C. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00198-0 · Cited by 117
Self-citationImke, C., Rodriguez, B. L., Grove, J. S., McNamara, J. R., Waslien, C., Katz, A. R., Willcox, B., Yano, K., & Curb, J. D. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000173310.85845.7b · Cited by 90
Sacks, F. M. (2006) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2006.05.004 · Cited by 85
Wang, T., Chen, W., Chien, K., Su, S., Hsu, H., Chen, M.-F., Liau, C., & Lee, Y. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01843-4 · Cited by 79
Self-citationBhalodkar, N. C., Blum, S., & Enas, E. A. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.10.036 · Cited by 69
Apolipoprotein B Versus Non–High-Density Lipoprotein Cholesterol: And the Winner Is…
Sniderman, A. D. (2005) · Circulation · doi:10.1161/circulationaha.105.583336 · Cited by 65
Keulen, E. T. P., Kruijshoop, M., Schaper, N. C., Hoeks, A. P. G., & de Bruin, T. W. A. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0202.104100 · Cited by 51
Curb, J. D., Abbott, R. D., Rodríguez, B. L., Masaki, K., Popper, J. S., Chen, R., Petrovitch, H., Blanchette, P. L., Schatz, I. J., & Yano, K. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52551.x · Cited by 48
Denke, M. A. (2005) · Circulation · doi:10.1161/circulationaha.105.588178 · Cited by 48
Simon, A. C., Chironi, G. N., Gariépy, J., Pino, M. D., & Levenson, J. A. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.10.017 · Cited by 47
Qureshi, A. I., Giles, W. H., Croft, J. B., Guterman, L. R., & Hopkins, L. N. (2002) · PubMed · Cited by 25
Koba, S., Hirano, T., Sakaue, T., Takeuchi, H. T., Adachi, M., & Katagiri, T. (2002) · Coronary Artery Disease · doi:10.1097/00019501-200208000-00002 · Cited by 24
Relative importance of atherosclerotic risk factors for coronary heart disease in Taiwan
Chien, K., Sung, F. C., Hsu, H. C., Su, T., Chang, W.-D., & Lee, Y.-T. (2005) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000161443.88679.8f · Cited by 21
Self-citationInsights from apoB: from better diagnosis & therapy to the Medusa Hypothesis
Sniderman, A. D., Williams, K., Haffner, S. M., & Sattar, N. A. (2004) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2004.03.005 · Cited by 11
Cited by
McQueen, M. J., Hawken, S., Wang, X., Ounpuu, S., Sniderman, A., Probstfield, J., Steyn, K., Sanderson, J. E., Hasani, M., Volkova, E., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61076-4 · Cited by 864
Lipoprotein Management in Patients With Cardiometabolic Risk
Brunzell, J. D., Davidson, M., Furberg, C. D., Goldberg, R. B., Howard, B. V., Stein, J. H., & Witztum, J. L. (2008) · Diabetes Care · doi:10.2337/dc08-9018 · Cited by 707
Sniderman, A. D., Williams, K., Contois, J. H., Monroe, H. M., McQueen, M. J., de Graaf, J., & Furberg, C. D. (2011) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.959247 · Cited by 659
ATUALIZAÇÃO DA DIRETRIZ BRASILEIRA DE DISLIPIDEMIAS E PREVENÇÃO DA ATEROSCLEROSE - 2017
Faludi, A., Izar, M., Saraiva, J., Chacra, A., Bianco, H., Afiune Neto, A., Bertolami, A., Pereira, A., Lottenberg, A., Sposito, A., et al. (2017) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20170121 · Cited by 633
Lipoprotein Management in Patients With Cardiometabolic Risk
Brunzell, J. D., Davidson, M., Furberg, C. D., Goldberg, R. B., Howard, B. V., Stein, J. H., & Witztum, J. L. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.034 · Cited by 529
Metadata
- Authors
- Chien, K.-L., Hsu, H.-C., Su, T.-C., Chen, M.-F., Lee, Y.-T., & Hu, F. B.
- Affiliations
- Harvard University (US)
- National Taiwan University Hospital (TW)
- Min Sheng General Hospital (TW)
- Corresponding author
- Chien, Kuo-Liong
- Lee, Yuan-Teh
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2007-11
- Volume
- 48
- Issue
- 11
- Pages
- 2499-2505
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W2087606026
- Cited by
- 109
- References
- 34
- Citations by year
- 2026: 1 · 2024: 3 · 2023: 3 · 2022: 12 · 2021: 4 · 2020: 3 · 2019: 2 · 2018: 8 · 2017: 7 · 2016: 3 · 2015: 3 · 2014: 5 · 2013: 5 · 2012: 7
- FWCI
- 11.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4733 d)
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- apolipoprotein B, non-HDL cholesterol, LDL cholesterol, coronary artery disease, cardiovascular risk prediction, lipid biomarkers, Chinese population, TC/HDL-C ratio
- MeSH terms
- Adult, Aged, Apolipoproteins B, China, Cholesterol, Coronary Disease, Female, Humans, Cholesterol, HDL, Cholesterol, LDL, Male, Middle Aged, Predictive Value of Tests, Prospective Studies, Risk, ROC Curve, Biomarkers, Asian People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.